Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis:A case report and literature review

lNTRODUCTlON

Primary splenic angiosarcoma(PSA),a subtype of soft tissue sarcoma(STS)with an annual incidence of 0.14-0.25 per million[1],is an extremely rare and aggressive mesenchymal malignancy with high metastatic potential and a poor prognosis.Upon histopathological examination,abnormal,pleomorphic,malignant patterns of endothelial cells,which can be rounded,polygonal,or fusiform(the hallmark of angiosarcoma or mitotic bodies),are commonly observed[2].The typically expressed endothelial markers include von Willebrand factor,CD34,CD31,Ulex europaeus agglutinin-1,and vascular endothelial growth factor(VEGF)[2].

I watched his dirt-caked fingers move slowly under each letter as he struggled to sound out “Bud the Sub.” It sounded more like “Baw Daw Saw” when he said it because of his speech impediment and his difficulty with the alphabet.

PSA patients with liver metastasis have a poor prognosis,especially when the spleen ruptures.Although immunotherapy and targeted therapy are widely used in other tumors,they are rarely considered in the treatment of PSA.In several cases,immunotherapy or targeted therapy is very effective in patients with angiosarcoma[3-5].We believe that this form of therapy may have great potential in the treatment of PSA.

CASE PRESENTATlON

Chief complaints

The patient developed pain in the right upper quadrant of the abdomen for one month,which exacerbated within a day,along with significant weight loss(Figure 1).

History of present illness

On 16 February 2020,a 49-year-old female with the complaint described above was brought to our emergency department.The patient did not report any abdominal trauma but complained of significant weight loss.According to the computed tomography(CT)scan on 16 February 2020 and other examinations(Figure 2),the diagnosis was non-traumatic splenic rupture and hemorrhage,with the suspected presence of liver cancer.Splenic artery embolization was suggested,which was refused by the patient and her family.Two days later,her abdominal pain was worse,after which,she and her family finally agreed to undergo splenic artery embolization(Figure 3).The patient recovered uneventfully and was discharged nine days later.One month later,she was admitted to our hospital again due to abdominal pain.According to the contrast-enhanced CT performed on 6 April 2020,the preliminary diagnosis was splenic angiosarcoma with peripheral and intrahepatic metastasis(Figure 4).

History of past illness

Surgical history included total thyroidectomy two years ago,followed by I131 therapy,hysteromyomectomy performed ten years ago,and pancreatic stone removal.The patient did not present a history of hepatitis or diabetes mellitus.

Personal and family history

One month after the operation,the patient was given an intravenous infusion of sorafenib(400 mg)twice daily and camrelizumab(200 mg)in a 21-d cycle.After three weeks of combination therapy,she developed hand-foot syndrome and was unable to walk,after which,sorafenib was reduced to 600 mg daily.

The patient was diagnosed as having PSA with a liver tumor.

Physical examination

The patient’s temperature was 36.6 °C,and blood pressure was 92/62 mmHg.Her heart rate was 101 bpm,and her respiratory rate was 20 breaths/min.Physical examination revealed a tender abdominal mass in the left upper abdomen and distension of the abdomen.Deep palpation showed diffuse pain,although without clinical signs of peritonitis.

Laboratory examinations

The authors have read the CARE Checklist(2016),and the manuscript was prepared and revised according to the CARE Checklist(2016).

Where the title chosen by the monarch has become a separate concept in the English language, the distinction whether this monarch would have been an emperor or a king is often no longer made: for instance caliph, sultan or khan as a concept of a type of monarch is usually defined separately, making it redundant22 to apply the emperor/king distinction to these types of monarchy ( Emperor Wikipedia 2006).

Imaging examinations

Immunotherapy has become a significant option for the treatment of advanced cancer[13].A retrospective analysis reported that a cohort of patients with unresectable sarcomas,who were treated with nivolumab combined with pazopanib,presented clinical benefit in 50% of the patients after at least four cycles[14].This may be due to increased lymphocytic infiltration and PD-L1 expression in patients with sarcomas[15,16].Hence,it is reasonable to perform immunotherapy.Studies have demonstrated that the activity of anti-PD-1 therapy in all types of STS is consistent[17].Targeted therapies such as bevacizumab,sorafenib,and pazopanib have shown great efficacy in the treatment of advanced STS[13].A retrospective analysis reported that sorafenib had activity against angiosarcoma[4].In a phase-III trial for metastatic STS,372 patients with advanced STS whose disease had progressed despite at least one line of chemotherapy were randomly assigned to either the pazopanib arm or a placebo arm.The difference in progression-free survival(PFS)between the two arms was statistically significant,with a median PFS of 4.6 mo for pazopanib,compared to just 1.6 mo for placebo[18].Pazopanib has received approval for the treatment of certain STSs in 2012[14].In an open-label,multicenter,phase-II study,bevacizumab showed great potential in the treatment of angiosarcoma in 30 patients,whose disease was deemed surgically unresectable,with a mean survival of 26 wk.Four patients showed partial response,and half of the patients had stable disease[3].Notably,all the reported targeted drugs were antiangiogenic agents,possibly because angiogenesis or VEGF plays an important role in carcinosarcoma[4].Moreover,a previous study suggested that combining immunotherapy and targeted therapies may have complementary roles in cancer treatment and that combinatorial therapy might be synergistic[5].That study gave us great inspiration and confidence.

FlNAL DlAGNOSlS

The little soldier inquired the meaning of all this noise, and was told that the Princess Ludovine, the King s beautiful daughter, had been found, and was about to make her triumphal entry

TREATMENT

Splenectomy and liver tumor resection were performed not only to perform radical excision of the tumor but also for histopathological diagnosis.Intraoperatively,we observed a large scleroid tumor mass of 4 cm × 6 cm in size in the upper pole of the spleen.A cross-section of the specimen revealed a demarcated yellowish-white lesion accompanied by hemorrhage and necrosis(Figure 5).The intraoperative observation of neoplasms was in line with the imaging findings.Histopathological biopsy and next-generation sequencing(NGS)were carried out(733 gene panel genetic testing provided by 3D Medicines Inc.).The histopathology revealed that the tumor cells were arranged in sheets,fissures,or papillae,with the cytoplasm in fusiform,oval,or irregular nuclei,and mitosis was easily seen.Immunohistochemical examination revealed that the tumor cells were positive for CD31,S-100 and Ki-67(positive rate of 60%),and negative for CD34(Figure 6).The final pathological diagnosis was hepatic angiosarcoma and splenic angiosarcoma.From imaging,it was observed that the splenic tumors were large and numerous,while the liver tumors were relatively small and uniform in size,which was consistent with the characteristics of metastatic liver cancer.In addition,our patient had no history of hepatitis,preoperative AFP was normal,CT examination showed no obvious characteristics of primary liver cancer,and blood from the spleen returned to the liver which is the way the tumor metastasizes,and further supported the diagnosis of spleen tumor metastasized to the liver.Although the primary site was indistinguishable pathologically,the diagnosis of primary splenic malignancy with hepatic metastasis was suggested based on the characteristics of imaging and blood metastasis.The NGS revealed somatic mutations in the PDGFRA(gene amplification),KIT(gene amplification),KDR(VEGFR2)(gene amplification),and TP53(c.376-4_380del,mutation abundance: 65.31%),while immunohistochemistry(IHC)showed the expression of programmed death ligand-1(PD-L1)(Figure 7).

There was no notable family medical history,such as cancer.

OUTCOME AND FOLLOW-UP

Three and a half months after the operation,no metastasis was observed on single-photon emission tomography-CT(Figure 8).After 15 mo of frequent follow-up,we happily report that the patient is in good condition without any recurrence or metastasis.Also,the side effects of sorafenib and camrelizumab were tolerable.The patient believed that the treatment had little impact on her quality of life.

DlSCUSSlON

Since the first case of PSA reported in 1879,only about 200 cases had been reported in the literature worldwide[1].We summarized the characteristics of PSA from case reports in the last ten years(Table 1).Unlike hepatic angiosarcoma,we observed no correlation between splenic angiosarcoma and risk factors such as thorium dioxide,vinyl chloride,or arsenic[6].The symptoms of PSA are nonspecific,and although it may occur at any age,it is commonly observed in females aged over 60 years old[6].

This request roused her to fury, since she had counted upon the Princess s fine robes to clothe her for the rest of her life, so that it was some time before the Prince could make himself heard to explain that he was willing to pay for them

Almost 30% of the patients experienced splenic rupture associated with hemoperitoneum[6].When the spleen ruptures,the prognosis for PSA patients is poor.Kornmann[8]reported that a 69-yearold male with PSA who had splenic rupture associated with hemoperitoneum died within one month after surgery(Table 1).Abbott[9]reported that the mean OS among patients who had splenectomy after spontaneous splenic rupture was 4.4 mo.If splenectomy was performed before rupture,the mean OS increased to 14.4 mo.

” The Snow Queen had said to him, “When you can find out this, you shall be your own master, and I will give you the whole world and a new pair of skates

PSA is also a highly aggressive tumor,which can not only spreaddirect invasion but also metastasizethe hematal and lymphatic system[2,7].The most common site involved is the liver,followed by the lungs,bones,lymph nodes,and ovaries[7].Metastasis in the liver,peritoneum,bone,and lung may occur in PSA patients,and approximately half of such patients died within one year after diagnosis(Table 1).The prognosis of PSA is abysmal,particularly in patients with metastases[6].Splenic rupture and liver metastases may serve as high-risk factors for PSA.Thus,the patients with either may need more measures for prolonged survival.Adjuvant therapy may be a potential treatment strategy after surgery to reduce the likelihood of recurrence or spread to other sites.

Postoperative radiotherapy and adjuvant chemotherapy provide a promising choice for sarcomas of the extremities,although the efficacy for PSA was questionable as only a few patients have been enrolled in clinical trials[10,11].For unresectable angiosarcoma,treatment with single-agent doxorubicin or paclitaxel is recommended based on the available evidence.However,there is no precise evidence for adjuvant chemotherapy[12].Given its extensive use in other tumors,targeted therapy and immunotherapy may provide new options for adjuvant therapy against PSA.

Multiple masses were observed in the liver and spleen on abdominal CT and magnetic resonance imaging on 16 February 2020(Figure 2).Contrast-enhanced CT on 6 April 2020 revealed multiple round shadows of low-density in the spleen and liver(Figure 4).

In the present case,the patient was treated with sorafenib combined with camrelizumab as adjuvant therapy,instead of chemotherapy,because we found that the prognoses of patients on chemotherapy were stratified,that is,chemotherapy worked well in some patients and presented unsatisfactory clinical outcomes in others[19-22].Therefore,we performed NGS and IHC for PD-L1.The patient may be sensitive to sorafenib(targets BRAF,CRAF,KIT,FLT3,RET,VEGFR-1/-2/-3,and PDGFRα/β)and PD-L1 inhibitor,as deduced from the mechanism of these drugs and thus received periodic treatment.This was a meaningful attempt of off label use.Now,after 15 mo of follow-up,there is no progress or recurrence of the disease,and the prognosis is good compared to most PSA patients with rupture of the spleen or liver metastases without adjuvant therapy among cases published in the last 10 years(Table 1).

Due to its low incidence,there are no recommended standardized treatments,guidelines,or even a consensus.Splenectomy is the preferred treatment for splenic angiosarcoma[2].According to a retrospective analysis by Li[7],the mean overall survival(OS)for PSA patients was less than 8.1 mo after diagnosis.Despite the long survival of some patients,the prognosis for patients with liver metastases or splenic rupture after splenectomy was generally poor(Table 1).

CONCLUSlON

Our data provide excellent evidence that adjuvant targeted therapy and immunotherapy may improve the prognosis in patients with PSA.Meanwhile,more evidence-based medical data and the specific cycle of targeted immunotherapy need to be further explored.NGS can be considered for patients suffering from angiosarcoma,which may suggest possible clinical treatment.

FOOTNOTES

Xiao Q was the physician in charge,confirmed the diagnosis and contributed the details on the histologic diagnosis;Pan D contributed to the case report design and manuscript drafting,and provided the histologic image;Wang SB and Chen YX were responsible for NGS testing;Li TP and Xiong JH reviewed the manuscript;Xiao Q and Li JF were the principal authors of the paper,had full access to all data,and are the guarantors;and all authors read and confirmed the final version of this article.

the Natural Science Foundation of Jiangxi Province(No.20192BAB215012 and No.20212BAB206027),the Health Commission of Jiangxi Province(No.20203206).

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

There is no conflict of interest to disclose.

Liver function tests,hematology parameters,as well as tumor markers such as α-fetoprotein(AFP),carbohydrate antigen 199,carcinoembryonic antigen,and chromogranin A,were all normal,except for a white blood cell count of 13.54 × 10/L[normal range:(4.0-10.0)× 10/L]and hemoglobin concentration of 177 g/L(normal range: 120-160 g/L),which were beyond the normal range.The D-dimer level of 35.65 mg/L(normal range: 0.0-0.55 mg/L)indicated high coagulation function,while the remaining parameters were normal.Electrolyte levels,electrocardiogram,and chest X-ray were normal.

One day he was in capital spirits because he had made a looking-glass which reflected everything that was good and beautiful in such a way that it dwindled1 almost to nothing, but anything that was bad and ugly stood out very clearly and looked much worse

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers.It is distributed in accordance with the Creative Commons Attribution NonCommercial(CC BYNC 4.0)license,which permits others to distribute,remix,adapt,build upon this work non-commercially,and license their derivative works on different terms,provided the original work is properly cited and the use is noncommercial.See: https://creativecommons.org/Licenses/by-nc/4.0/

China

So the merchant married the widow and brought her home as his wife, but the little girl soon found that her foster mother was very far from being what her father had thought

Dan Pan 0000-0001-5535-8331;Tai-Ping Li 0000-0002-3365-2676;Jian-Hui Xiong 0000-0003-0000-4338;Shu-Bo Wang 0000-0003-2470-7214;Yao-Xu Chen 0000-0002-8850-4267;Jian-Feng Li 0000-0001-9426-2842;Qi Xiao 0000-0002-3849-2755.

Wang JJ

Whereupon he began, with a voice like a screech-owl s, to chant the words of his opera, only this time happily not at such a length, and without the frog accompaniment

Webster JR

Nine suitors had already lost their lives when the King s son arrived, and, dazzled by her beauty, determined13 to risk his life in hopes of winning her

Wang JJ